Agilent Technologies, Inc. $A Stock Sold by Impax Asset Management Group plc

Agilent Technologies logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Impax Asset Management cut its Agilent stake by 38.1% in the third quarter, selling 638,988 shares and retaining 1,035,969 shares worth about $178.5 million.
  • Agilent beat quarterly earnings and revenue estimates, reporting EPS of $1.62 versus $1.49 expected and revenue of $1.88 billion, up 8.1% year over year.
  • Analyst sentiment remained positive: 18 analysts rated the stock Buy and four Hold, resulting in a “Moderate Buy” consensus and an average price target of $181.45.
  • Five stocks we like better than Agilent Technologies.

Impax Asset Management Group plc reduced its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 38.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,035,969 shares of the medical research company's stock after selling 638,988 shares during the period. Agilent Technologies accounts for 1.4% of Impax Asset Management Group plc's portfolio, making the stock its 20th biggest holding. Impax Asset Management Group plc owned 0.37% of Agilent Technologies worth $178,508,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Bank of New York Mellon Corp raised its stake in Agilent Technologies by 87.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company's stock worth $695,227,000 after acquiring an additional 2,440,360 shares during the period. Legal & General Group Plc purchased a new position in Agilent Technologies during the second quarter valued at approximately $260,101,000. Bank of America Corp DE bought a new position in shares of Agilent Technologies in the second quarter worth approximately $213,269,000. Man Group plc bought a new position in shares of Agilent Technologies in the second quarter worth approximately $179,257,000. Finally, Primecap Management Co. CA bought a new position in shares of Agilent Technologies in the second quarter worth approximately $176,318,000.

Insider Buying and Selling

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the business's stock in a transaction on Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the sale, the director owned 4,924 shares in the company, valued at $745,395.12. The trade was a 11.41% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Agilent Technologies Trading Down 0.4%

Shares of A opened at $172.29 on Wednesday. The firm has a market cap of $48.58 billion, a P/E ratio of 28.53, a price-to-earnings-growth ratio of 2.54 and a beta of 1.24. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $182.99. The company has a 50 day simple moving average of $169.37 and a two-hundred day simple moving average of $138.58.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter in the previous year, the firm earned $1.37 earnings per share. The company's quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, equities analysts expect that Agilent Technologies, Inc. will post 6.20 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th were issued a $0.2550 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date was Tuesday, October 6th. Agilent Technologies's payout ratio is currently 20.08%.

Analyst Upgrades and Downgrades

A has been the topic of several recent analyst reports. Evercore raised their price objective on shares of Agilent Technologies from $148.00 to $178.00 and gave the company an "outperform" rating in a research report on Wednesday, October 7th. Stifel Nicolaus lifted their target price on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a "buy" rating in a research note on Thursday, August 27th. TD Cowen upped their target price on shares of Agilent Technologies from $180.00 to $196.00 and gave the stock a "buy" rating in a report on Tuesday, October 13th. Wells Fargo & Company increased their price target on Agilent Technologies from $160.00 to $180.00 and gave the stock an "overweight" rating in a research note on Friday, August 28th. Finally, Robert W. Baird increased their price target on Agilent Technologies from $180.00 to $195.00 and gave the stock an "outperform" rating in a research note on Thursday, October 8th. Eighteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, Agilent Technologies presently has a consensus rating of "Moderate Buy" and a consensus target price of $181.45.

View Our Latest Stock Report on Agilent Technologies

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

See Also

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Agilent Technologies Right Now?

Before you consider Agilent Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.

While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines